An engineered protein turns off the kind of immune cells most likely to damage tissue as part of Type-1 diabetes, hepatitis, multiple sclerosis, shows...

NEW YORK, June 30, 2025 /PRNewswire/ -- An engineered protein turns off the kind of immune cells most likely to damage tissue as part of Type-1...

NEW YORK, June 30, 2025 /PRNewswire/ -- An engineered protein turns off the kind of immune cells most likely to damage tissue as part of Type-1...

Scientists at St. Jude Children’s Research Hospital and Dana-Farber Cancer Institute, USA, report the identification of a novel combination therapy...

Scientists at St. Jude Children’s Research Hospital and Dana-Farber Cancer Institute, USA, report the identification of a novel combination therapy...

ADMA's surging Asceniv demand and bold revenue forecasts set it apart in the competitive plasma therapies space.

ADMA's surging Asceniv demand and bold revenue forecasts set it apart in the competitive plasma therapies space.

The article discusses how somatoform disorders can be treated through cognitive behavioral therapy, Scripture, and community support for lasting...

Researchers from The University of Osaka find that a protein expressed on malaria-infected red blood cells both hides it from the immune system and...

A recent breakthrough by scientists at the University of California, San Francisco, offers a fresh and promising path toward treating Alzheimer’s...